Protalix BioTherapeutics Inc.

ASE:PLX

1.10

-0.15 (-12.00%)

7:47:11 PM EDT: $1.09 -0.01 (-0.91%)

Protalix BioTherapeutics Inc. Stock, ASE:PLX

2 University Plaza, Suite 100, Hackensack, New Jersey 07601

United States of America

Phone: +972 4 902-8100

Number of Employees: 208

http://www.protalix.com

Description

Protalix Biotherapeutics, Inc. is a biopharmaceutical company, which engages in the development, production, and commercialization of recombinant therapeutic proteins based on plant cell based expression system. Its products include Alidornase alfa, PRX-115 and PRX-11. The company was by Yoseph Shaaltiel in 1993 and is headquartered in Hackensack, NJ.